CRISPR Therapeutics AG
$CRSP
Public valuation for CRISPR Therapeutics AG (CRSP). Fair value, signal, and key metrics — no sign-in required.
Current Price
$51.42
99% Overvalued
Fair Value Estimate
$0
📉
Distressed
Negative earnings with declining revenue
Analyst Consensus
Target: $85.63
67% higher than current
Key Metrics
Market Cap
$5.0B
Forward P/E
23.4x
Operating Margin
-1151.8%
Revenue Growth
-66.6%
Get free watchlist alerts
Join the waitlist for valuation updates on $CRSP and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.